title: More on: Platelet count and the use of recombinant factor VIIa for the treatment of bleeding complications after hematopoietic stem cell transplantation.
authors.forename: M
authors.initials: M
authors.lastname: Marietta
authors.forename: L
authors.initials: L
authors.lastname: Facchini
authors.forename: M
authors.initials: M
authors.lastname: Girardis
authors.forename: M
authors.initials: M
authors.lastname: Luppi
authors.forename: G
authors.initials: G
authors.lastname: Torelli
mesh_terms: D000740:Anemia; D005167:Factor VII / Q000627:therapeutic use*; D015942:Factor VIIa; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006470:Hemorrhage / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D010976:Platelet Count; D011994:Recombinant Proteins / Q000627:therapeutic use; D013921:Thrombocytopenia
chemical_list: D011994:Recombinant Proteins; D005167:Factor VII; C103587:recombinant FVIIa; D015942:Factor VIIa